Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial Membrane Stabilization (MMS)
- Target
- MMS
- Molecular classification
- Multi-component system, Lipid-protein interaction network, Structural maintenance pathway
01
Overview
Mitochondrial membrane stabilization encompasses the processes and components responsible for maintaining the structural and functional integrity of the inner and outer mitochondrial membranes. This stability is critical for efficient energy production, regulation of cell death pathways, and overall cellular health. Key factors involved include the mitochondrial membrane potential (ΔΨm), protein complexes like OPA1 and the MICOS complex, and lipids such as cardiolipin. Disruptions in mitochondrial membrane stabilization can lead to a variety of diseases, making it a target for therapeutic intervention.
- Other names
- Mitochondrial membrane integrityMitochondrial membrane potential maintenanceMitochondrial homeostasisMaintenance of mitochondrial structure and function
02
Mechanism of action
Various, including: - Inhibition of mPTP opening - Modulation of Bcl-2 family protein activity - Stabilization of OPA1-cardiolipin interactions - Enhancement of MICOS complex function
03
Biological functions
Energy production (ATP synthesis)Regulation of apoptosisRegulation of necrosisMitochondrial dynamics (fusion/fission)Maintenance of mitochondrial membrane potential (ΔΨm)Prevention of cytochrome c releaseCalcium buffering
04
Disease associations
Neurodegenerative diseasesCardiovascular diseases (ischemia/reperfusion injury)CancerMetabolic disordersAgingDrug-induced toxicityMitochondrial disorders
05
Safety considerations
Off-target effects on other cellular processesPotential for disrupting mitochondrial dynamicsUnintended consequences on cell death pathwaysDrug-induced mitochondrial toxicityReperfusion injury
06
Interacting drugs
Doxorubicin
2 more in the full profile.
07
Biomarkers
Mitochondrial membrane potential (ΔΨm)Cytochrome c releaseCaspase activationMitochondrial ROS productionmPTP openingLevels of OPA1, MICOS subunits, and Bcl-2 family proteinsCardiolipin content
Beyond the preview
Go deeper on Mitochondrial Membrane Stabilization (MMS).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mitochondrial Membrane Stabilization (MMS).